peptide,lca,superkingdom,kingdom,subkingdom,superphylum,phylum,subphylum,superclass,class,subclass,infraclass,superorder,order,suborder,infraorder,parvorder,superfamily,family,subfamily,tribe,subtribe,genus,subgenus,species group,species subgroup,species,subspecies,varietas,forma,EC,EC - names,GO (cellular component),GO (molecular function),GO (biological process),GO (cellular component) - names,GO (molecular function) - names,GO (biological process) - names,InterPro,InterPro - names
LSSPATLNSR,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,3.4.21.4 (100%),Trypsin (100%),GO:0005615 (11%);GO:0016021 (2%),extracellular space (11%);integral component of membrane (2%),GO:0004252 (100%);GO:0046872 (4%),serine-type endopeptidase activity (100%);metal ion binding (4%),GO:0006508 (11%);GO:0007586 (4%),proteolysis (11%);digestion (4%),IPR001254 (100%);IPR009003 (100%);IPR043504 (100%),Serine proteases, trypsin domain (100%);Peptidase S1, PA clan (100%);Peptidase S1, PA clan, chymotrypsin-like fold (100%)
LSSPATLDSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SPATLNSR,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,,,,,GO:0004252 (100%),serine-type endopeptidase activity (100%),,,IPR001254 (100%);IPR001314 (100%);IPR009003 (100%),Serine proteases, trypsin domain (100%);Peptidase S1A, chymotrypsin family (100%);Peptidase S1, PA clan (100%)
VATVSPLR,Solirubrobacteraceae,Bacteria,,,,Actinobacteria,,,Thermoleophilia,,,Solirubrobacterales,,,,Solirubrobacteraceae,,,,,,,,,,,,,,,,GO:0005886 (100%);GO:0016021 (100%),plasma membrane (100%);integral component of membrane (100%),,,,,IPR003838 (100%);IPR025857 (100%),ABC3 transporter permease protein domain (100%);MacB-like periplasmic core domain (100%)
VVTVSLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005524 (100%);GO:0008134 (100%);GO:0043565 (100%),ATP binding (100%);transcription factor binding (100%);sequence-specific DNA binding (100%),GO:0000160 (100%);GO:0006355 (100%),phosphorelay signal transduction system (100%);regulation of transcription, DNA-templated (100%),IPR001789 (100%);IPR002078 (100%);IPR002197 (100%),Signal transduction response regulator, receiver domain (100%);RNA polymerase sigma factor 54 interaction domain (100%);DNA binding HTH domain,  Fis-type (100%)
VVTVLSPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0007165 (100%),signal transduction (100%),IPR000157 (100%);IPR035897 (100%),Toll/interleukin-1 receptor homology (TIR) domain (100%);Toll/interleukin-1 receptor homology (TIR) domain superfamily (100%)
QEFLNAAK,Phorcysia thermohydrogeniphila,Bacteria,,,,Aquificae,,,Aquificae,,,Desulfurobacteriales,,,,Desulfurobacteriaceae,,,,Phorcysia,,,,Phorcysia thermohydrogeniphila,,,,,,,,,,GO:0009055 (100%);GO:0020037 (100%);GO:0046872 (100%),electron transfer activity (100%);heme binding (100%);metal ion binding (100%),,,IPR009056 (100%),Cytochrome c-like domain (100%)
LATVLSPR,Gammaproteobacteria,Bacteria,,,,Proteobacteria,,,Gammaproteobacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,IPR002634 (100%);IPR036065 (100%),BolA protein (100%);BolA-like superfamily (100%)
ELYLSWVVEAR,Sarcopterygii,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,,,,,,,,,,,,,,,,,,,,,,1.6.2.4 (100%),NADPH--hemoprotein reductase (100%),GO:0016021 (90%);GO:0005789 (76%);GO:0005783 (8%),integral component of membrane (90%);endoplasmic reticulum membrane (76%);endoplasmic reticulum (8%),GO:0010181 (95%);GO:0003958 (88%);GO:0050660 (76%),FMN binding (95%);NADPH-hemoprotein reductase activity (88%);flavin adenine dinucleotide binding (76%),GO:0009725 (5%);GO:0003420 (2%);GO:0007584 (2%),response to hormone (5%);regulation of growth plate cartilage chondrocyte proliferation (2%);response to nutrient (2%),IPR003097 (100%);IPR017938 (100%);IPR023173 (100%),Sulfite reductase [NADPH] flavoprotein alpha-component-like, FAD-binding (100%);Riboflavin synthase-like beta-barrel (100%);NADPH-cytochrome p450 reductase, FAD-binding, alpha-helical domain superfamily (100%)
MVLNAAVYK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LSSPATLSNR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SSPATLNDK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VPGVSLPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MHFPHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ELYLSWVNNVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SLVNLGSGK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0009279 (100%),cell outer membrane (100%),GO:0005509 (100%);GO:0016829 (100%),calcium ion binding (100%);lyase activity (100%),,,IPR000531 (100%);IPR002022 (100%);IPR003598 (100%),TonB-dependent receptor-like, beta-barrel (100%);Pectate lyase (100%);Immunoglobulin subtype 2 (100%)
APVLSDSSCK,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,3.4.21.4 (100%),Trypsin (100%),GO:0005615 (33%),extracellular space (33%),GO:0004252 (100%);GO:0046872 (17%),serine-type endopeptidase activity (100%);metal ion binding (17%),GO:0006508 (33%);GO:0007586 (17%),proteolysis (33%);digestion (17%),IPR001254 (100%);IPR001314 (100%);IPR009003 (100%),Serine proteases, trypsin domain (100%);Peptidase S1A, chymotrypsin family (100%);Peptidase S1, PA clan (100%)
MNLGAYK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016757 (100%),glycosyltransferase activity (100%),,,IPR001296 (100%);IPR028098 (100%),Glycosyl transferase, family 1 (100%);Glycosyltransferase subfamily 4-like, N-terminal domain (100%)
ELYLSWVPMAR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HMFPHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SMVFDLLK,Caloramator fervidus,Bacteria,,,,Firmicutes,,,Clostridia,,,Eubacteriales,,,,Clostridiaceae,,,,Caloramator,,,,Caloramator fervidus,,,,,,,,,,GO:0005524 (100%);GO:0017111 (100%),ATP binding (100%);nucleoside-triphosphatase activity (100%),,,IPR004948 (100%);IPR027417 (100%);IPR029063 (100%),Nucleoside-triphosphatase, THEP1 type (100%);P-loop containing nucleoside triphosphate hydrolase (100%);S-adenosyl-L-methionine-dependent methyltransferase (100%)
DMLGAYK,Eubacteriales,Bacteria,,,,Firmicutes,,,Clostridia,,,Eubacteriales,,,,,,,,,,,,,,,,,,5.3.1.9 (100%),Glucose-6-phosphate isomerase (100%),GO:0005737 (100%),cytoplasm (100%),GO:0004347 (100%),glucose-6-phosphate isomerase activity (100%),GO:0006094 (100%);GO:0006096 (100%),gluconeogenesis (100%);glycolytic process (100%),IPR010551 (100%);IPR011051 (100%);IPR014710 (100%),Glucose-6-phosphate isomerase, prokaryote (100%);RmlC-like cupin domain superfamily (100%);RmlC-like jelly roll fold (100%)
MHMLHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MHLMHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HMPMHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SCSSYR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.3.1.98 (100%),UDP-N-acetylmuramate dehydrogenase (100%),GO:0016021 (89%);GO:0020002 (3%);GO:0020030 (3%),integral component of membrane (89%);host cell plasma membrane (3%);infected host cell surface knob (3%),GO:0046789 (68%);GO:0005267 (9%);GO:0005524 (5%),host cell surface receptor binding (68%);potassium channel activity (9%);ATP binding (5%),GO:0009405 (68%);GO:0020013 (3%);GO:0020033 (3%),obsolete pathogenesis (68%);modulation by symbiont of host erythrocyte aggregation (3%);antigenic variation (3%),IPR004258 (65%);IPR041480 (65%);IPR042202 (64%),Duffy-binding-like domain (65%);Cysteine-rich interdomain region 1 gamma (65%);Duffy-antigen binding superfamily (64%)
QLACAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.5.1.8 (97%);6.5.1.- (1%);3.6.-.- (0%),3'-phosphate/5'-hydroxy nucleic acid ligase (97%);Forming phosphoric ester bonds (1%);Acting on acid anhydrides (0%),GO:0072669 (74%);GO:0005737 (26%);GO:0005829 (7%),tRNA-splicing ligase complex (74%);cytoplasm (26%);cytosol (7%),GO:0005525 (92%);GO:0046872 (92%);GO:0003972 (74%),GTP binding (92%);metal ion binding (92%);RNA ligase (ATP) activity (74%),GO:0006388 (71%);GO:0008033 (17%);GO:0000971 (4%),tRNA splicing, via endonucleolytic cleavage and ligation (71%);tRNA processing (17%);tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate (4%),IPR001233 (88%);IPR036025 (88%);IPR027513 (72%),RNA-splicing ligase, RtcB (88%);tRNA-splicing ligase RtcB-like superfamily (88%);RNA-splicing ligase RtcB homologue, eukaryotic (72%)
QPMHLTAQSK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VHVSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.3.12 (30%);3.4.24.- (7%);2.7.11.1 (7%),6-pyruvoyltetrahydropterin synthase (30%);Metalloendopeptidases (7%);Non-specific serine/threonine protein kinase (7%),GO:0016021 (31%);GO:0005886 (6%);GO:0005737 (5%),integral component of membrane (31%);plasma membrane (6%);cytoplasm (5%),GO:0005524 (30%);GO:0004176 (17%);GO:0004222 (17%),ATP binding (30%);ATP-dependent peptidase activity (17%);metalloendopeptidase activity (17%),GO:0006729 (7%);GO:0015074 (3%);GO:0006351 (2%),tetrahydrobiopterin biosynthetic process (7%);DNA integration (3%);transcription, DNA-templated (2%),IPR002678 (27%);IPR036069 (27%);IPR027417 (16%),GTP cyclohydrolase 1 type 2/Nif3 (27%);GTP cyclohydrolase 1 type 2/Nif3 superfamily (27%);P-loop containing nucleoside triphosphate hydrolase (16%)
KPMHLTEER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YLHPGDPK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VWAHLEGSNK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MFFSHLYVPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CMGDDAAATK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LATVHVAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
WYYHLTANTK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MHLMHLTAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FEHVHLTEER,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SHYEK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.14.11.67 (21%);3.6.4.12 (7%);2.3.2.27 (5%),[Histone H3]-trimethyl-L-lysine(4) demethylase (21%);DNA helicase (7%);RING-type E3 ubiquitin transferase (5%),GO:0005737 (29%);GO:0034451 (25%);GO:0016021 (18%),cytoplasm (29%);centriolar satellite (25%);integral component of membrane (18%),GO:0005524 (8%);GO:0046872 (8%);GO:0003677 (7%),ATP binding (8%);metal ion binding (8%);DNA binding (7%),GO:1902018 (25%);GO:0045944 (4%);GO:0019346 (3%),negative regulation of cilium assembly (25%);positive regulation of transcription by RNA polymerase II (4%);transsulfuration (3%),IPR026099 (23%);IPR026102 (23%);IPR027417 (8%),Outer dense fibre protein 2-related (23%);Protein BCAP (23%);P-loop containing nucleoside triphosphate hydrolase (8%)
DPPSTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.99.18 (33%);3.1.-.- (33%);3.1.1.- (33%),Dolichyl-diphosphooligosaccharide--protein glycotransferase (33%);Acting on ester bonds (33%);Carboxylic ester hydrolases (33%),GO:0005634 (22%);GO:0016021 (13%);GO:0005730 (9%),nucleus (22%);integral component of membrane (13%);nucleolus (9%),GO:0005085 (17%);GO:0046872 (17%);GO:0031625 (9%),guanyl-nucleotide exchange factor activity (17%);metal ion binding (17%);ubiquitin protein ligase binding (9%),GO:0035556 (13%);GO:0000463 (9%);GO:0000466 (9%),intracellular signal transduction (13%);maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (9%);maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (9%),IPR011993 (14%);IPR000219 (10%);IPR001331 (10%),PH-like domain superfamily (14%);Dbl homology (DH) domain (10%);Guanine-nucleotide dissociation stimulator, CDC24, conserved site (10%)
GSGGGSSGGSLGGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0045095 (100%);GO:0005886 (53%);GO:0001533 (44%),keratin filament (100%);plasma membrane (53%);cornified envelope (44%),GO:0046982 (47%);GO:0030246 (44%);GO:0030280 (44%),protein heterodimerization activity (47%);carbohydrate binding (44%);structural constituent of skin epidermis (44%),GO:0050728 (47%);GO:0051290 (47%);GO:0061436 (47%),negative regulation of inflammatory response (47%);protein heterotetramerization (47%);establishment of skin barrier (47%),IPR032449 (100%);IPR003054 (97%);IPR039008 (97%),Keratin type II cytoskeletal 1, tail (100%);Keratin, type II (97%);Intermediate filament, rod domain (97%)
LVNELTEFAK,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,,,GO:0005615 (88%);GO:0032991 (17%);GO:0005783 (13%),extracellular space (88%);protein-containing complex (17%);endoplasmic reticulum (13%),GO:0046872 (71%);GO:0003677 (17%);GO:0005504 (17%),metal ion binding (71%);DNA binding (17%);fatty acid binding (17%),GO:0009267 (17%);GO:0043066 (17%);GO:0051659 (17%),cellular response to starvation (17%);negative regulation of apoptotic process (17%);maintenance of mitochondrion location (17%),IPR000264 (100%);IPR014760 (100%);IPR020858 (100%),ALB/AFP/VDB (100%);Serum albumin, N-terminal (100%);Serum albumin-like (100%)
VPQVSTPTLVEVSR,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,,,GO:0005615 (83%);GO:0005783 (22%);GO:0005794 (22%),extracellular space (83%);endoplasmic reticulum (22%);Golgi apparatus (22%),GO:0046872 (55%);GO:1903981 (21%);GO:0003677 (20%),metal ion binding (55%);enterobactin binding (21%);DNA binding (20%),GO:0009267 (20%);GO:0043066 (20%);GO:0051659 (20%),cellular response to starvation (20%);negative regulation of apoptotic process (20%);maintenance of mitochondrion location (20%),IPR000264 (100%);IPR014760 (100%);IPR020858 (100%),ALB/AFP/VDB (100%);Serum albumin, N-terminal (100%);Serum albumin-like (100%)
GNEQFLNAAK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VATVSLPR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.4 (100%),Trypsin (100%),GO:0005615 (29%),extracellular space (29%),GO:0004252 (100%);GO:0046872 (14%),serine-type endopeptidase activity (100%);metal ion binding (14%),GO:0006508 (29%);GO:0007586 (14%),proteolysis (29%);digestion (14%),IPR001254 (100%);IPR001314 (100%);IPR009003 (100%),Serine proteases, trypsin domain (100%);Peptidase S1A, chymotrypsin family (100%);Peptidase S1, PA clan (100%)
SLVNLGGSK,Mammalia,Eukaryota,Metazoa,,,Chordata,Craniata,Sarcopterygii,Mammalia,,,,,,,,,,,,,,,,,,,,,,,GO:0045095 (100%);GO:0005886 (61%);GO:0001533 (33%),keratin filament (100%);plasma membrane (61%);cornified envelope (33%),GO:0046982 (35%);GO:0030246 (33%);GO:0030280 (33%),protein heterodimerization activity (35%);carbohydrate binding (33%);structural constituent of skin epidermis (33%),GO:0051290 (35%);GO:0001867 (33%);GO:0018149 (33%),protein heterotetramerization (35%);complement activation, lectin pathway (33%);peptide cross-linking (33%),IPR003054 (100%);IPR032444 (100%);IPR039008 (100%),Keratin, type II (100%);Keratin type II head (100%);Intermediate filament, rod domain (100%)
VVTLVSPR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016020 (100%),membrane (100%),GO:0008137 (100%);GO:0051539 (100%),NADH dehydrogenase (ubiquinone) activity (100%);4 iron, 4 sulfur cluster binding (100%),GO:0042773 (100%),ATP synthesis coupled electron transport (100%),IPR000283 (100%);IPR001041 (100%);IPR006656 (100%),NADH:ubiquinone oxidoreductase, 75kDa subunit, conserved site (100%);2Fe-2S ferredoxin-type iron-sulfur binding domain (100%);Molybdopterin oxidoreductase (100%)
LNLLFVDGK,Paramecium tetraurelia,Eukaryota,,,,Ciliophora,Intramacronucleata,,Oligohymenophorea,,,Peniculida,,,,Parameciidae,,,,Paramecium,,,,Paramecium tetraurelia,,,,,,,,,,,,,,,
LYDQMLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.1.3.15 (100%),Glucose-6-phosphate 1-epimerase (100%),GO:0005634 (10%);GO:0005840 (10%);GO:0016021 (10%),nucleus (10%);ribosome (10%);integral component of membrane (10%),GO:0003824 (20%);GO:0016765 (20%);GO:0030246 (20%),catalytic activity (20%);transferase activity, transferring alkyl or aryl (other than methyl) groups (20%);carbohydrate binding (20%),GO:0005975 (20%);GO:0008612 (20%);GO:0006352 (10%),carbohydrate metabolic process (20%);peptidyl-lysine modification to peptidyl-hypusine (20%);DNA-templated transcription, initiation (10%),IPR001242 (20%);IPR002773 (20%);IPR008183 (20%),Condensation domain (20%);Deoxyhypusine synthase (20%);Aldose 1-/Glucose-6-phosphate 1-epimerase (20%)
MTLLGALAR,Acyrthosiphon pisum,Eukaryota,Metazoa,,,Arthropoda,Hexapoda,,Insecta,Pterygota,,Hemiptera,Sternorrhyncha,Aphidomorpha,Aphidoidea,Aphididae,Aphidinae,Macrosiphini,,Acyrthosiphon,,,,Acyrthosiphon pisum,,,,,,,,,,GO:0046872 (100%),metal ion binding (100%),,,IPR027805 (100%);IPR027806 (100%),Transposase, Helix-turn-helix domain (100%);Harbinger transposase-derived nuclease domain (100%)
LVESLTK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.2.1.49 (20%);2.7.7.8 (12%);2.8.1.7 (12%),Urocanate hydratase (20%);Polyribonucleotide nucleotidyltransferase (12%);Cysteine desulfurase (12%),GO:0016021 (34%);GO:0005737 (22%);GO:0005886 (20%),integral component of membrane (34%);cytoplasm (22%);plasma membrane (20%),GO:0000287 (9%);GO:0003779 (9%);GO:0005506 (9%),magnesium ion binding (9%);actin binding (9%);iron ion binding (9%),GO:0007165 (10%);GO:0045104 (9%);GO:0006119 (8%),signal transduction (10%);intermediate filament cytoskeleton organization (9%);oxidative phosphorylation (8%),IPR001452 (8%);IPR002017 (8%);IPR002048 (8%),SH3 domain (8%);Spectrin repeat (8%);EF-hand domain (8%)
DLLQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.6 (14%);2.7.13.3 (6%);2.7.7.7 (4%),DNA-directed RNA polymerase (14%);Histidine kinase (6%);DNA-directed DNA polymerase (4%),GO:0016021 (19%);GO:0005737 (12%);GO:0005886 (5%),integral component of membrane (19%);cytoplasm (12%);plasma membrane (5%),GO:0005524 (21%);GO:0003677 (13%);GO:0046872 (9%),ATP binding (21%);DNA binding (13%);metal ion binding (9%),GO:0006351 (3%);GO:0051301 (2%);GO:0006355 (2%),transcription, DNA-templated (3%);cell division (2%);regulation of transcription, DNA-templated (2%),IPR027417 (12%);IPR011009 (4%);IPR003593 (3%),P-loop containing nucleoside triphosphate hydrolase (12%);Protein kinase-like domain superfamily (4%);AAA+ ATPase domain (3%)
LVFVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (30%);1.1.1.298 (14%);2.1.1.- (11%),DNA helicase (30%);3-hydroxypropionate dehydrogenase (NADP(+)) (14%);Methyltransferases (11%),GO:0016021 (21%);GO:0005737 (9%);GO:1990077 (9%),integral component of membrane (21%);cytoplasm (9%);primosome complex (9%),GO:0003677 (15%);GO:0005524 (15%);GO:0003678 (9%),DNA binding (15%);ATP binding (15%);DNA helicase activity (9%),GO:0006269 (9%);GO:0006412 (8%);GO:0006212 (4%),DNA replication, synthesis of RNA primer (9%);translation (8%);uracil catabolic process (4%),IPR027417 (16%);IPR009000 (10%);IPR029033 (7%),P-loop containing nucleoside triphosphate hydrolase (16%);Translation protein, beta-barrel domain superfamily (10%);Histidine phosphatase superfamily (7%)
LGEHNLDVL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LLLHK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (6%);3.1.-.- (5%);2.7.13.3 (4%),DNA helicase (6%);Acting on ester bonds (5%);Histidine kinase (4%),GO:0005737 (41%);GO:0016021 (18%);GO:0005886 (5%),cytoplasm (41%);integral component of membrane (18%);plasma membrane (5%),GO:0003723 (39%);GO:0005524 (9%);GO:0003677 (6%),RNA binding (39%);ATP binding (9%);DNA binding (6%),GO:0070929 (36%);GO:0015031 (2%);GO:0016192 (2%),trans-translation (36%);protein transport (2%);vesicle-mediated transport (2%),IPR000037 (32%);IPR023620 (32%);IPR020081 (29%),SsrA-binding protein (32%);Small protein B (32%);SsrA-binding protein, conserved site (29%)
NNMTQK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6.1.1.14 (64%);2.7.7.6 (14%);1.8.4.11 (7%),Glycine--tRNA ligase (64%);DNA-directed RNA polymerase (14%);Peptide-methionine (S)-S-oxide reductase (7%),GO:0005737 (41%);GO:0016021 (7%);GO:0000502 (4%),cytoplasm (41%);integral component of membrane (7%);proteasome complex (4%),GO:0003677 (41%);GO:0005524 (37%);GO:0004820 (33%),DNA binding (41%);ATP binding (37%);glycine-tRNA ligase activity (33%),GO:0006426 (33%);GO:0006351 (7%);GO:0009405 (7%),glycyl-tRNA aminoacylation (33%);transcription, DNA-templated (7%);obsolete pathogenesis (7%),IPR002315 (33%);IPR004154 (33%);IPR006195 (33%),Glycyl-tRNA synthetase (33%);Anticodon-binding (33%);Aminoacyl-tRNA synthetase, class II (33%)
HLVVSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.4.2.29 (27%);3.6.4.12 (20%);6.3.3.2 (20%),tRNA-guanine(34) transglycosylase (27%);DNA helicase (20%);5-formyltetrahydrofolate cyclo-ligase (20%),GO:0032039 (15%);GO:0016021 (10%);GO:0005634 (8%),integrator complex (15%);integral component of membrane (10%);nucleus (8%),GO:0005524 (24%);GO:0003700 (8%);GO:0043531 (8%),ATP binding (24%);DNA-binding transcription factor activity (8%);ADP binding (8%),GO:0016180 (15%);GO:0006281 (12%);GO:0006310 (12%),snRNA processing (15%);DNA repair (12%);DNA recombination (12%),IPR007372 (42%);IPR036761 (42%);IPR027417 (13%),Lipid/polyisoprenoid-binding, YceI-like (42%);Lipid/polyisoprenoid-binding, YceI-like superfamily (42%);P-loop containing nucleoside triphosphate hydrolase (13%)
ATEEQLK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (36%);3.4.23.- (14%);1.4.1.13 (7%),Peptidylprolyl isomerase (36%);Aspartic endopeptidases (14%);Glutamate synthase (NADPH) (7%),GO:0016021 (40%);GO:0005737 (35%);GO:0005730 (11%),integral component of membrane (40%);cytoplasm (35%);nucleolus (11%),GO:0046872 (42%);GO:0051536 (36%);GO:0043022 (11%),metal ion binding (42%);iron-sulfur cluster binding (36%);ribosome binding (11%),GO:0000054 (11%);GO:0006364 (11%);GO:0006450 (11%),ribosomal subunit export from nucleus (11%);rRNA processing (11%);regulation of translational fidelity (11%),IPR036869 (32%);IPR001623 (32%);IPR017896 (32%),Chaperone J-domain superfamily (32%);DnaJ domain (32%);4Fe-4S ferredoxin-type, iron-sulphur binding domain (32%)
EHLFGR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.21.89 (15%);2.4.1.207 (12%);2.7.13.3 (12%),Signal peptidase I (15%);Xyloglucan:xyloglucosyl transferase (12%);Histidine kinase (12%),GO:0016021 (14%);GO:0005739 (10%);GO:0005634 (5%),integral component of membrane (14%);mitochondrion (10%);nucleus (5%),GO:0003824 (29%);GO:0003677 (13%);GO:0005524 (12%),catalytic activity (29%);DNA binding (13%);ATP binding (12%),GO:0005975 (29%);GO:0006139 (6%);GO:0008380 (4%),carbohydrate metabolic process (29%);nucleobase-containing compound metabolic process (6%);RNA splicing (4%),IPR004352 (25%);IPR013785 (25%);IPR016062 (25%),Glycoside-hydrolase family GH114, TIM-barrel domain (25%);Aldolase-type TIM barrel (25%);Hypothetical protein TM1410-related (25%)
VLYAFSTLFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
YVASLR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.8.- (15%);2.1.1.- (8%);2.4.2.18 (8%),Transferases for other substituted phosphate groups (15%);Methyltransferases (8%);Anthranilate phosphoribosyltransferase (8%),GO:0016021 (14%);GO:0005886 (10%);GO:0005737 (10%),integral component of membrane (14%);plasma membrane (10%);cytoplasm (10%),GO:0005524 (16%);GO:0046872 (14%);GO:0003677 (12%),ATP binding (16%);metal ion binding (14%);DNA binding (12%),GO:0042147 (8%);GO:0006355 (8%);GO:0006605 (5%),retrograde transport, endosome to Golgi (8%);regulation of transcription, DNA-templated (8%);protein targeting (5%),IPR027417 (12%);IPR039766 (6%);IPR007234 (6%),P-loop containing nucleoside triphosphate hydrolase (12%);Vacuolar protein sorting-associated protein 53 (6%);Vps53-like, N-terminal (6%)
FLLLSEPR,Eukaryota,Eukaryota,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0005783 (33%);GO:0005794 (33%);GO:0030008 (33%),endoplasmic reticulum (33%);Golgi apparatus (33%);TRAPP complex (33%),GO:0043531 (67%),ADP binding (67%),GO:0006888 (33%);GO:0006952 (33%),endoplasmic reticulum to Golgi vesicle-mediated transport (33%);defense response (33%),IPR002182 (67%);IPR027417 (67%);IPR032675 (67%),NB-ARC (67%);P-loop containing nucleoside triphosphate hydrolase (67%);Leucine-rich repeat domain superfamily (67%)
LGALFVGGLVK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SSPATLNSR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
RPAPTPGPPR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VRPSLHLQR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EYNMK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.2.1.8 (9%);3.5.1.- (7%);5.4.99.12 (7%),Peptidylprolyl isomerase (9%);In linear amides (7%);tRNA pseudouridine(38-40) synthase (7%),GO:0016021 (18%);GO:0005576 (10%);GO:0019028 (5%),integral component of membrane (18%);extracellular region (10%);viral capsid (5%),GO:0016491 (15%);GO:0016810 (13%);GO:0046872 (9%),oxidoreductase activity (15%);hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds (13%);metal ion binding (9%),GO:0005975 (16%);GO:0007420 (10%);GO:0035082 (10%),carbohydrate metabolic process (16%);brain development (10%);axoneme assembly (10%),IPR027968 (23%);IPR036291 (12%);IPR000683 (10%),Jhy protein (23%);NAD(P)-binding domain superfamily (12%);Gfo/Idh/MocA-like oxidoreductase, N-terminal (10%)
VVHLSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.7.7.- (42%);2.7.1.17 (18%);2.4.1.131 (7%),Nucleotidyltransferases (42%);Xylulokinase (18%);GDP-Man:Man(3)GlcNAc(2)-PP-dolichol alpha-1,2-mannosyltransferase (7%),GO:0016021 (26%);GO:0035098 (18%);GO:0005737 (17%),integral component of membrane (26%);ESC/E(Z) complex (18%);cytoplasm (17%),GO:0003677 (21%);GO:0005524 (13%);GO:0001227 (13%),DNA binding (21%);ATP binding (13%);DNA-binding transcription repressor activity, RNA polymerase II-specific (13%),GO:0000027 (12%);GO:0007165 (11%);GO:0006935 (8%),ribosomal large subunit assembly (12%);signal transduction (11%);chemotaxis (8%),IPR013087 (58%);IPR036236 (58%);IPR001790 (6%),Zinc finger C2H2-type (58%);Zinc finger C2H2 superfamily (58%);Ribosomal protein L10P (6%)
LLGFALPLR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
MMAPAFAQAADGFK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
QQLSK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.13 (30%);2.7.7.7 (20%);5.6.2.1 (5%),Methionine synthase (30%);DNA-directed DNA polymerase (20%);DNA topoisomerase (5%),GO:0016021 (19%);GO:0005737 (13%);GO:0005634 (11%),integral component of membrane (19%);cytoplasm (13%);nucleus (11%),GO:0008270 (10%);GO:0005524 (10%);GO:0003677 (10%),zinc ion binding (10%);ATP binding (10%);DNA binding (10%),GO:0032259 (10%);GO:0042558 (8%);GO:0006281 (6%),methylation (10%);pteridine-containing compound metabolic process (8%);DNA repair (6%),IPR027417 (9%);IPR004223 (8%);IPR037010 (8%),P-loop containing nucleoside triphosphate hydrolase (9%);Vitamin B12-dependent methionine synthase, activation domain (8%);Vitamin B12-dependent methionine synthase, activation domain superfamily (8%)
DGNWA,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.4.11.- (82%);3.4.11.24 (18%),Aminopeptidases (82%);Aminopeptidase S (18%),,,GO:0004177 (98%);GO:0008237 (98%);GO:0046872 (98%),aminopeptidase activity (98%);metallopeptidase activity (98%);metal ion binding (98%),GO:0005975 (2%),carbohydrate metabolic process (2%),IPR000787 (98%);IPR035097 (98%);IPR005846 (2%),Peptidase M29 (98%);Peptidase M29, N-terminal (98%);Alpha-D-phosphohexomutase, alpha/beta/alpha domain III (2%)
LVVFR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.25 (33%);7.1.1.- (9%);2.7.13.3 (5%),tRNA pseudouridine(55) synthase (33%);Hydron translocation or charge separation linked to oxidoreductase reactions (9%);Histidine kinase (5%),GO:0016021 (21%);GO:0005886 (9%);GO:0005840 (9%),integral component of membrane (21%);plasma membrane (9%);ribosome (9%),GO:0005524 (17%);GO:0046872 (13%);GO:0016887 (11%),ATP binding (17%);metal ion binding (13%);ATPase (11%),GO:0006412 (9%);GO:0031119 (4%);GO:0000271 (3%),translation (9%);tRNA pseudouridine synthesis (4%);polysaccharide biosynthetic process (3%),IPR027417 (14%);IPR003593 (12%);IPR003439 (10%),P-loop containing nucleoside triphosphate hydrolase (14%);AAA+ ATPase domain (12%);ABC transporter-like (10%)
AHAEALGLTTGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LPATDLTVVHR,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0043190 (100%),ATP-binding cassette (ABC) transporter complex (100%),GO:0042301 (100%),phosphate ion binding (100%),GO:0035435 (100%),phosphate ion transmembrane transport (100%),IPR005673 (100%);IPR024370 (100%),Phosphate ABC transporter, substrate-binding protein PstS (100%);PBP domain (100%)
VGGQSGVVFAVGLLMVFLVL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GGPAR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.12 (14%);3.6.4.13 (6%);2.7.13.3 (4%),DNA helicase (14%);RNA helicase (6%);Histidine kinase (4%),GO:0016021 (40%);GO:0005743 (14%);GO:0005886 (7%),integral component of membrane (40%);mitochondrial inner membrane (14%);plasma membrane (7%),GO:0005509 (14%);GO:0005524 (12%);GO:0003677 (6%),calcium ion binding (14%);ATP binding (12%);DNA binding (6%),GO:0055085 (15%);GO:0032259 (2%);GO:0006325 (2%),transmembrane transport (15%);methylation (2%);chromatin organization (2%),IPR018108 (13%);IPR023395 (13%);IPR011992 (12%),Mitochondrial substrate/solute carrier (13%);Mitochondrial carrier domain superfamily (13%);EF-hand domain pair (12%)
YLSTVR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.1.1.298 (27%);1.1.1.267 (13%);2.3.1.61 (7%),Ribosomal protein L3 N(5)-glutamine methyltransferase (27%);1-deoxy-D-xylulose-5-phosphate reductoisomerase (13%);Dihydrolipoyllysine-residue succinyltransferase (7%),GO:0005634 (13%);GO:0016021 (12%);GO:0005737 (6%),nucleus (13%);integral component of membrane (12%);cytoplasm (6%),GO:0003677 (39%);GO:0005524 (7%);GO:0003697 (7%),DNA binding (39%);ATP binding (7%);single-stranded DNA binding (7%),GO:0000160 (35%);GO:0006355 (35%);GO:0006281 (7%),phosphorelay signal transduction system (35%);regulation of transcription, DNA-templated (35%);DNA repair (7%),IPR036388 (30%);IPR001867 (29%);IPR039420 (29%),Winged helix-like DNA-binding domain superfamily (30%);OmpR/PhoB-type DNA-binding domain (29%);Transcriptional regulatory protein WalR-like (29%)
MTVTNWNLLFG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VPYGDLK,Bacteria,Bacteria,,,,,,,,,,,,,,,,,,,,,,,,,,,,2.6.1.82 (50%);6.1.1.6 (50%),Putrescine--2-oxoglutarate transaminase (50%);Lysine--tRNA ligase (50%),GO:0005737 (50%),cytoplasm (50%),GO:0000287 (50%);GO:0003676 (50%);GO:0004824 (50%),magnesium ion binding (50%);nucleic acid binding (50%);lysine-tRNA ligase activity (50%),GO:0006430 (50%),lysyl-tRNA aminoacylation (50%),IPR002313 (50%);IPR004364 (50%);IPR004365 (50%),Lysine-tRNA ligase, class II (50%);Aminoacyl-tRNA synthetase, class II (D/K/N) (50%);OB-fold nucleic acid binding domain, AA-tRNA synthetase-type (50%)
AMLDPNTADVTAR,Cyanobacteria,Bacteria,,,,Cyanobacteria,,,,,,,,,,,,,,,,,,,,,,,,5.4.99.17 (91%);4.2.1.129 (8%);5.4.99.37 (2%),Squalene--hopene cyclase (91%);Squalene--hopanol cyclase (8%);Dammaradiene synthase (2%),GO:0005811 (99%);GO:0016021 (0%),lipid droplet (99%);integral component of membrane (0%),GO:0000250 (99%);GO:0042300 (99%);GO:0051007 (41%),lanosterol synthase activity (99%);beta-amyrin synthase activity (99%);squalene-hopene cyclase activity (41%),GO:0019746 (99%),hopanoid biosynthetic process (99%),IPR006400 (100%);IPR008930 (100%);IPR018333 (100%),Squalene hopene cyclase (100%);Terpenoid cyclases/protein prenyltransferase alpha-alpha toroid (100%);Squalene cyclase (100%)
LLDALNR,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.6.4.- (24%);2.6.1.16 (8%);2.1.1.201 (5%),Acting on ATP; involved in cellular and subcellular movement (24%);Glutamine--fructose-6-phosphate transaminase (isomerizing) (8%);2-methoxy-6-polyprenyl-1,4-benzoquinol methylase (5%),GO:0009428 (14%);GO:0030288 (14%);GO:0016021 (13%),bacterial-type flagellum basal body, distal rod, P ring (14%);outer membrane-bounded periplasmic space (14%);integral component of membrane (13%),GO:0005524 (18%);GO:0005198 (14%);GO:0003677 (8%),ATP binding (18%);structural molecule activity (14%);DNA binding (8%),GO:0071973 (14%);GO:0006355 (7%);GO:0000716 (5%),bacterial-type flagellum-dependent cell motility (14%);regulation of transcription, DNA-templated (7%);transcription-coupled nucleotide-excision repair, DNA damage recognition (5%),IPR027417 (15%);IPR001782 (11%);IPR029787 (8%),P-loop containing nucleoside triphosphate hydrolase (15%);Flagellar P-ring protein (11%);Nucleotide cyclase (8%)
TNYLMHNSFYLVGK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LFLVLPSR,Marchantia polymorpha,Eukaryota,Viridiplantae,,,Streptophyta,Streptophytina,,Marchantiopsida,Marchantiidae,,Marchantiales,,,,Marchantiaceae,,,,Marchantia,,,,Marchantia polymorpha,,,,,,,,,,,,,,IPR001810 (100%);IPR015915 (100%);IPR036047 (100%),F-box domain (100%);Kelch-type beta propeller (100%);F-box-like domain superfamily (100%)
LGEHNLD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
KPTLH,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,GO:0016021 (85%);GO:0005886 (23%);GO:0005829 (8%),integral component of membrane (85%);plasma membrane (23%);cytosol (8%),GO:0016757 (23%);GO:0016740 (15%);GO:0005524 (8%),glycosyltransferase activity (23%);transferase activity (15%);ATP binding (8%),GO:0006355 (8%),regulation of transcription, DNA-templated (8%),IPR036255 (99%);IPR011978 (99%);IPR007456 (0%),YgfB-like superfamily (99%);Uncharacterised protein family UPF0149 (99%);Smg (0%)
LLELHWK,root,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1.8.4.11 (100%),Peptide-methionine (S)-S-oxide reductase (100%),,,GO:0003677 (25%);GO:0004803 (25%);GO:0005524 (25%),DNA binding (25%);transposase activity (25%);ATP binding (25%),GO:0006313 (25%);GO:0006464 (25%);GO:0006749 (25%),transposition, DNA-mediated (25%);cellular protein modification process (25%);glutathione metabolic process (25%),IPR001270 (25%);IPR002110 (25%);IPR002513 (25%),ClpA/B family (25%);Ankyrin repeat (25%);Tn3 transposase DDE domain (25%)